Related Experiment Video
Updated: Jun 20, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Doxorubicin-mediated apoptosis in glioma cells requires NFAT3
Sreelatha Gopinath1, Sravan K Vanamala, Meena Gujrati
1Department of Cancer Biology and Pharmacology, College of Medicine at Peoria, University of Illinois, 1649 Peoria, IL 61656, USA.
Abstract:
Nuclear factor of activated T cells (NFAT), a family of transcription factors, has been implicated in many cellular processes, including some cancers. Here, we characterize, for the first time, the role of NFAT3 in doxorubicin (DOX)-mediated apoptosis, migration, and invasion in SNB19 and U87 glioma cells. This study demonstrates that the specific knockdown of NFAT3 results in a dramatic inhibition of the apoptotic effect induced by DOX and favors cell survival. Inhibition of NFAT3 activation by shNFAT3 (shNF3) significantly downregulated tumor necrosis factor (TNF)-alpha induction, its receptor TNFR1, caspase 10, caspase 3, and poly (ADP-ribose) polymerase, abrogating DOX-mediated apoptosis in glioma cells. DOX treatment resulted in NFAT3 translocation to the nucleus. Similarly, shNF3 treatment in SNB19 and U87 cells reversed DOX-induced inhibition of cell migration and invasion, as determined by wound healing and matrigel invasion assays. Taken together, these results indicate that NFAT3 is a prerequisite for the induction of DOX-mediated apoptosis in glioma cells.
Insights
Nuclear factor of activated T cells 3 (NFAT3) is crucial for doxorubicin-induced apoptosis in glioma cells. Inhibiting NFAT3 promotes cell survival and reverses the effects of doxorubicin on migration and invasion.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Nuclear factor of activated T cells (NFAT) transcription factors regulate critical cellular processes.
- NFAT family members have been linked to various cancers.
- The specific role of NFAT3 in glioma response to chemotherapy is not well understood.
Purpose of the Study:
- To investigate the role of NFAT3 in doxorubicin (DOX)-induced apoptosis, migration, and invasion in SNB19 and U87 glioma cells.
- To elucidate the molecular mechanisms by which NFAT3 influences chemoresistance and cell motility.
Main Methods:
- Specific knockdown of NFAT3 using shNFAT3 (shNF3).
- Doxorubicin (DOX) treatment of glioma cell lines.
- Analysis of apoptosis-related proteins (TNF-alpha, TNFR1, caspase 10, caspase 3, PARP).
- Assessment of cell migration and invasion using wound healing and matrigel assays.
- Monitoring NFAT3 translocation to the nucleus via DOX treatment.
Main Results:
- NFAT3 knockdown significantly inhibited doxorubicin-mediated apoptosis, promoting glioma cell survival.
- Inhibition of NFAT3 downregulated key apoptotic markers including TNF-alpha, TNFR1, caspase 10, caspase 3, and PARP.
- Doxorubicin treatment induced NFAT3 nuclear translocation.
- NFAT3 inhibition reversed doxorubicin-induced suppression of cell migration and invasion.
Conclusions:
- NFAT3 is essential for the induction of doxorubicin-mediated apoptosis in glioma cells.
- NFAT3 plays a critical role in regulating chemoresistance, cell survival, migration, and invasion in response to doxorubicin.
- Targeting NFAT3 may represent a novel therapeutic strategy for overcoming doxorubicin resistance in gliomas.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Apoptosis
